Media stories about CorVel (NASDAQ:CRVL) have been trending positive on Thursday, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CorVel earned a media sentiment score of 0.30 on Accern’s scale. Accern also assigned press coverage about the business services provider an impact score of 45.8358226415832 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Separately, BidaskClub downgraded shares of CorVel from a “buy” rating to a “hold” rating in a report on Wednesday.
Shares of CRVL stock traded up $0.90 during mid-day trading on Thursday, hitting $50.55. The company had a trading volume of 42,879 shares, compared to its average volume of 36,898. CorVel has a 52-week low of $40.70 and a 52-week high of $61.20. The company has a market capitalization of $945.89, a PE ratio of 27.77 and a beta of 0.71.
CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.